Design, synthesis, and anti-integrase activity of catechol-DKA hybrids

被引:23
作者
Maurin, C
Bailly, F
Mbemba, G
Mouscadet, JF
Cotelle, P [1 ]
机构
[1] Univ Sci & Technol Lille, CNRS, UMR 8009, Lab Chim Organ & Macromol, F-59655 Villeneuve Dascq, France
[2] ENS Cachan, CNRS, UMR 8113, Lab Biotechnol & Pharmacol Genet Appl, F-94235 Cachan, France
关键词
antiviral; HIV-1 integrase inhibitors; DKA; catechols;
D O I
10.1016/j.bmc.2005.12.039
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Following the discovery of diketoacid-containing compounds as HIV-1 integrase (IN) inhibitors, a plethora of new molecules have been published leading to four drugs under clinical trial. In an attempt to rationally design new dimeric diketoacids (DKAs) targeting two divalent metal ions on the active site of IN, potent inhibitors against purified IN were found with varied selectivity for strand transfer. In this context, we designed and synthesized a new series of catechol-DKA hybrids. These compounds presented micromolar anti-integrase activities with moderate antiviral properties. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2978 / 2984
页数:7
相关论文
共 30 条
[1]   Mode of interaction of G-quartets with the integrase of human immunodeficiency virus type 1 [J].
Cherepanov, P ;
Este, JA ;
Rando, RF ;
Ojwang, JO ;
Reekmans, G ;
Steinfeld, R ;
David, G ;
De Clercq, E ;
Debyser, Z .
MOLECULAR PHARMACOLOGY, 1997, 52 (05) :771-780
[2]   Therapies: Confronting the limits of success [J].
Cohen, J .
SCIENCE, 2002, 296 (5577) :2320-2324
[3]   6-aryl-2,4-dioxo-5-hexenoic acids, novel integrase inhibitors active against HIV-1 multiplication in cell-based assays [J].
Costi, R ;
Di Santo, R ;
Artico, M ;
Roux, A ;
Ragno, R ;
Massa, S ;
Tramontano, E ;
La Colla, M ;
Loddo, R ;
Marongiu, ME ;
Pani, A ;
La Colla, P .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (07) :1745-1749
[4]   Active site binding modes of the β-diketoacids:: a multi-active site approach in HIV-1 integrase inhibitor design [J].
Dayam, R ;
Neamati, N .
BIOORGANIC & MEDICINAL CHEMISTRY, 2004, 12 (24) :6371-6381
[5]   Human immunodeficiency virus glycoprotein gp120 as the primary target for the antiviral action of AR177 (Zintevir) [J].
Esté, JA ;
Cabrera, C ;
Schols, D ;
Cherepanov, P ;
Gutierrez, A ;
Witvrouw, M ;
Pannecouque, C ;
Debyser, Z ;
Rando, RF ;
Clotet, B ;
Desmyter, J ;
De Clercq, E .
MOLECULAR PHARMACOLOGY, 1998, 53 (02) :340-345
[6]   Differential inhibition of HIV-1 preintegration complexes and purified integrase protein by small molecules [J].
Farnet, CM ;
Wang, BB ;
Lipford, JR ;
Bushman, FD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (18) :9742-9747
[7]   Human immunodeficiency virus type 1 cDNA integration: New aromatic hydroxylated inhibitors and studies of the inhibition mechanism [J].
Farnet, CM ;
Wang, B ;
Hansen, M ;
Lipford, JR ;
Zalkow, L ;
Robinson, WE ;
Siegel, J ;
Bushman, F .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (09) :2245-2253
[8]   Structure of the HIV-1 integrase catalytic domain complexed with an inhibitor: A platform for antiviral drug design [J].
Goldgur, Y ;
Craigie, R ;
Cohen, GH ;
Fujiwara, T ;
Yoshinaga, T ;
Fujishita, T ;
Sugimoto, H ;
Endo, T ;
Murai, H ;
Davies, DR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (23) :13040-13043
[9]   Diketo acid inhibitor mechanism and HIV-1 integrase: Implications for metal binding in the active site of phosphotransferase enzymes [J].
Grobler, JA ;
Stillmock, K ;
Hu, BH ;
Witmer, M ;
Felock, P ;
Espeseth, AS ;
Wolfe, A ;
Egbertson, M ;
Bourgeois, M ;
Melamed, J ;
Wai, JS ;
Young, S ;
Vacca, J ;
Hazuda, DJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (10) :6661-6666
[10]   Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells [J].
Hazuda, DJ ;
Felock, P ;
Witmer, M ;
Wolfe, A ;
Stillmock, K ;
Grobler, JA ;
Espeseth, A ;
Gabryelski, L ;
Schleif, W ;
Blau, C ;
Miller, MD .
SCIENCE, 2000, 287 (5453) :646-650